Blog

Propensity of Deflazacort in current market (Q3, 2019)

MedAnalytics

Deflazacort is clinically used for Allergic and inflammatory disorders. The trends of using Deflazacort in the medical practice has been changing over the time.It looks like, doctor's preference for using Deflazacort appears to be elevated in the recent clinical practice. In the year 2016, around 14% doctors used to prefer Deflazacort whenever indication for a Glucocorticoids came-across in clinical management. Presently, approx 20% doctors prefer Deflazacort for clinical indication; is expected to 26% over the forecast period of 2020 - 2022. A simultaneous changes in the preference is expected for other Glucocorticoids.In addition, an increased incidence of related diseases are presumed to be the key contributing factors providing a fillip this generic vertical. Increased awareness, availability of drugs by the key companies, rising demand for improved healthcare are some of the major factors.Furthermore, the presence of high unmet clinical needs with regard to treatment issue is the factor propelling the expansion of this vertical. This modality of treatment is expected to gain popularity in the coming years as generic provides better medication compliance.

You might be interested to